Key Points
- IKE 2.0 initially targets nicotine products and combines identity verification, product authentication, policy controls and data analytics.
- Ispire holds a 40% interest in IKE Tech and committed up to $10 million under the original joint-venture agreement.
- IKE Tech submitted an age-verification component PMTA in April 2025, which FDA accepted in May; the technology has not received marketing authorization.
- IKE Tech said a 102-participant human factors study blocked all attempted underage activations, though the study has not been peer-reviewed.
2Firsts
September 29, 2026
IKE Tech LLC launched IKE 2.0 on September 28, introducing a compliance platform initially aimed at nicotine products that combines user identity verification, product authentication, configurable policy controls and data analytics.
The system can authenticate products through direct device integration or NFC smart tags and apply different access rules by jurisdiction, product and SKU. It also includes a web interface for manufacturers and brand operators and a configurable consumer-facing application.
Expanding Beyond Age Verification
IKE Tech's earlier development work centered on age verification at the point of use for e-cigarette devices.
IKE 2.0 broadens that approach across four areas: identity, product authentication, policy management and analytics.
The identity layer verifies users and converts the result into a digital identity credential. The product layer is designed to authenticate and trace products, while policy settings can vary by market, product and SKU. A separate analytics layer processes platform and device data.
Product authentication can be built directly into a device or handled through NFC smart tags.
The launch broadens IKE Tech's focus from age gating alone to post-sale access controls, product authentication and policy enforcement.
Ispire Holds 40% Stake, With Up to $10 Million Committed
IKE Tech was formed in 2024.
SEC filings from Ispire show that the venture involves its wholly owned subsidiary Aspire North America LLC, Chemular Inc. and Touch Point Worldwide Inc., which operates as Berify.
Under the original agreement, Aspire North America and Berify each received a 40% interest, while Chemular received 20%.
Ispire's latest annual filing shows that Aspire North America continues to hold a 40% stake in IKE Tech.
Ispire initially contributed $1 million in cash for operating expenses and committed to provide up to another $9 million, bringing its total potential investment to $10 million.
The venture was originally established to develop age-verification technology for vapor devices and pursue related PMTA filings in the U.S.
Age-Verification Component PMTA Remains Under FDA Review
IKE Tech submitted a component PMTA for its age-verification system in April 2025, and FDA accepted the application the following month.
Ispire's latest annual filing shows that the application remains under review, with the company still awaiting further FDA feedback.
IKE Tech has described the filing as the first standalone component PMTA in the U.S. for interoperable age-verification technology. FDA public materials do not independently rank or confirm that characterization.
Acceptance of the application means it entered FDA's review process. It does not constitute marketing authorization.
FDA Draft Guidance Discusses Device Access Restrictions
FDA issued draft guidance in March 2026 on flavored ENDS premarket applications, including potential approaches to reducing youth access.
The draft discusses device access restriction technologies such as biometric authentication, geofencing and continuous age verification. It also notes that minimum-age laws and point-of-sale ID checks do not directly control product use after purchase.
The document remains draft, non-binding guidance and does not represent FDA endorsement of IKE Tech's technology.
IKE Tech also met with FDA's Center for Tobacco Products in April for a listening session focused on point-of-use age controls, illicit products in the ENDS supply chain and possible regulatory treatment of compliance software.
Company Reports Results From 102-Participant Study
IKE Tech said its age-verification system was evaluated in a controlled human factors study involving 102 participants.
According to the company, all attempted underage device activations were blocked. Adult participants gave the system a 91% ease-of-use rating, while the user error rate was below 1%.
The study has not been peer-reviewed, and the public materials do not provide the full age breakdown of participants, the number of underage subjects, the complete study protocol or full statistical results.
IKE Tech also cautioned that performance in a controlled setting may not be replicated exactly in real-world use.
Patents and Security Certification Form Part of the Platform Offering
IKE Tech says the platform is covered by 11 issued patents spanning identity, authentication and policy-governance infrastructure, with additional applications pending.
IKE 2.0 is also SOC 2 Type II certified and designed around GDPR and CCPA requirements. Under the architecture described by the company, verified identity information can be converted into a digital credential, while biometric processing is handled primarily on-device.
The patent count, certification status and architecture details are based on company disclosures.
Commercial Deployment Details Remain Undisclosed
IKE Tech has positioned nicotine as IKE 2.0's first market, with plans to expand into cannabis, healthcare, medical products, gaming and other age- or identity-restricted categories.
The launch announcement did not identify paying customers or name e-cigarette brands or manufacturers using the platform commercially.
Pricing, connected-device volumes, contract values and revenue expectations were also not disclosed.
For now, the main disclosed milestones are the launch of IKE 2.0 and the continued FDA review of IKE Tech's earlier age-verification technology.
Follow 2Firsts for updates on vape age verification, PMTA and compliance technology.
Cover Image: IKE Tech
